BCRX - Biocryst Pharmaceuticals Inc - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - BCRX (882796)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
15 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2023-06-15
BCRXSanders MachelleDirS - Sale+OE$7.98-4,00025,611-14%-$31,920
D
2023-06-14
BCRXHutson Nancy JDirS - Sale+OE$8.04-12,86681,818-14%-$103,443
2023-04-03
BCRXThackray Helen M.Chief R, D OfficerS - Sale$8.29-7,000207,275-3%-$58,030
D
2023-02-01
BCRXStonehouse Jon PPres, CEOS - Sale+OE$10.38-100,0001,028,739-9%-$1,038,000
2022-12-15
BCRXStonehouse Jon PPres, CEOS - Sale$10.90-14,100897,730-2%-$153,690
2022-12-15
BCRXThackray Helen M.Chief R, D OfficerS - Sale$10.89-3,125133,275-2%-$34,031
2022-12-15
BCRXDoyle AnthonyCFOS - Sale$10.90-5,700163,966-3%-$62,130
2022-12-15
BCRXGayer Charles KChief Commercial OfficerS - Sale$10.90-6,100211,610-3%-$66,490
2022-12-15
BCRXJones Michael LExec. Dir, Finance - PAOS - Sale$10.90-44510,753-4%-$4,851
2022-12-15
BCRXBarnes Alane PGCS - Sale$10.88-4,175198,770-2%-$45,424
D
2022-12-01
BCRXJones Michael LExec. Dir, Finance - PAOS - Sale+OE$13.01-8,60011,198-43%-$111,886
DM
2022-12-01
BCRXStonehouse Jon PPres, CEOS - Sale+OE$12.94-297,573911,830-25%-$3,851,918
D
2022-11-14
BCRXBabu Yarlagadda SChief Discovery OfficerS - Sale+OE$13.88-31,515298,541-10%-$437,428
D
2022-04-18
BCRXAbercrombie George BDirS - Sale+OE$11.04-5,0000-100%-$55,200
2022-04-01
BCRXThackray Helen M.Chief R, D OfficerS - Sale$16.20-7,600136,400-5%-$123,120

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top